Drugs / MK-7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07861464 | Jan 2025 → Jul 2026 | benign paroxysmal positional vertigo | University of Jordan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-7 | “The combined regimen consisted of cholecalciferol 4000 IU daily and men-aquinone-7 (MK-7) 200 μg daily for 12 months.” NCT07861464 ↗ |
| Known as | men-aquinone-7 | “The combined regimen consisted of cholecalciferol 4000 IU daily and men-aquinone-7 (MK-7) 200 μg daily for 12 months.” NCT07861464 ↗ |